Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 10
1991 13
1992 9
1993 19
1994 19
1995 24
1996 35
1997 45
1998 33
1999 105
2000 70
2001 51
2002 52
2003 91
2004 63
2005 89
2006 106
2007 145
2008 115
2009 139
2010 124
2011 154
2012 152
2013 165
2014 164
2015 147
2016 146
2017 129
2018 125
2019 112
2020 132
2021 136
2022 159
2023 120
2024 76

Text availability

Article attribute

Article type

Publication date

Search Results

2,919 results

Results by year

Filters applied: . Clear all
Page 1
HLA-G and Recurrent Pregnancy Loss.
Barbaro G, Inversetti A, Cristodoro M, Ticconi C, Scambia G, Di Simone N. Barbaro G, et al. Int J Mol Sci. 2023 Jan 29;24(3):2557. doi: 10.3390/ijms24032557. Int J Mol Sci. 2023. PMID: 36768880 Free PMC article. Review.
Although the cross talk between the two systems is complex and not completely understood, Human Leukocyte Antigen G (HLA-G), expressed on trophoblastic cell surfaces, seems to be one of the main molecules involved in the modulation of both local and systemic materna …
Although the cross talk between the two systems is complex and not completely understood, Human Leukocyte Antigen G (HLA-G), e …
HLA-G Neo-Expression on Tumors.
Loustau M, Anna F, Dréan R, Lecomte M, Langlade-Demoyen P, Caumartin J. Loustau M, et al. Front Immunol. 2020 Aug 14;11:1685. doi: 10.3389/fimmu.2020.01685. eCollection 2020. Front Immunol. 2020. PMID: 32922387 Free PMC article. Review.
Consequently, HLA-G appears to be an excellent molecular target for immunotherapy. ...Here, we summarize the current knowledge about HLA-G neo-expression and implication in various tumor types, pointing out the need for the development of new tools to …
Consequently, HLA-G appears to be an excellent molecular target for immunotherapy. ...Here, we summarize the current knowledge …
HLA-G expression in melanomas.
Marletta S, Girolami I, Munari E, Pantanowitz L, Bernasconi R, Torresani E, Brunelli M, Eccher A. Marletta S, et al. Int Rev Immunol. 2021;40(5):330-343. doi: 10.1080/08830185.2020.1869732. Epub 2021 Jan 11. Int Rev Immunol. 2021. PMID: 33426980 Review.
The aim of the study is to review the published literature on the expression of HLA-G in malignant melanomas and its clinicopathological and prognostic correlates. ...Evidence further suggests that HLA-G is not implicated in the immunobiology of uveal …
The aim of the study is to review the published literature on the expression of HLA-G in malignant melanomas and its clinicopa …
HLA-G: Function, polymorphisms and pathology.
Arnaiz-Villena A, Juarez I, Suarez-Trujillo F, López-Nares A, Vaquero C, Palacio-Gruber J, Martin-Villa JM. Arnaiz-Villena A, et al. Int J Immunogenet. 2021 Apr;48(2):172-192. doi: 10.1111/iji.12513. Epub 2020 Oct 1. Int J Immunogenet. 2021. PMID: 33001562 Review.
HLA-G immune modulatory genes and molecules are presently being studied by a widespread number of research groups. ...On the other hand, we question whether performing mainly studies on HLA-G and disease associations is going to give a clear answer in …
HLA-G immune modulatory genes and molecules are presently being studied by a widespread number of research groups. ...On the o …
HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease.
Martín-Villa JM, Vaquero-Yuste C, Molina-Alejandre M, Juarez I, Suárez-Trujillo F, López-Nares A, Palacio-Gruber J, Barrera-Gutiérrez L, Fernández-Cruz E, Rodríguez-Sainz C, Arnaiz-Villena A. Martín-Villa JM, et al. Front Immunol. 2022 Jan 27;13:796054. doi: 10.3389/fimmu.2022.796054. eCollection 2022. Front Immunol. 2022. PMID: 35154112 Free PMC article. Review.
HLA-G is a non-classical HLA class I molecule with immunomodulatory properties. ...HLA-G neo-expression on tumors has been recently described in several types of malignancies. ...
HLA-G is a non-classical HLA class I molecule with immunomodulatory properties. ...HLA-G neo-expression on tumor …
HLA-G: A New Immune Checkpoint in Cancer?
Krijgsman D, Roelands J, Hendrickx W, Bedognetti D, Kuppen PJK. Krijgsman D, et al. Int J Mol Sci. 2020 Jun 25;21(12):4528. doi: 10.3390/ijms21124528. Int J Mol Sci. 2020. PMID: 32630545 Free PMC article. Review.
Many studies have claimed HLA-G as a new immune checkpoint in cancer. Therefore, HLA-G and its receptors might be targets for immune checkpoint blockade in cancer immunotherapy. ...These studies should focus on tumor expression patterns of the seven di …
Many studies have claimed HLA-G as a new immune checkpoint in cancer. Therefore, HLA-G and its receptors might b …
HLA-G and the MHC Cusp Theory.
Scavuzzi BM, van Drongelen V, Holoshitz J. Scavuzzi BM, et al. Front Immunol. 2022 Feb 25;13:814967. doi: 10.3389/fimmu.2022.814967. eCollection 2022. Front Immunol. 2022. PMID: 35281038 Free PMC article. Review.
Human leukocyte antigens (HLA) are significant genetic risk factors in a long list of diseases. ...Relevant to the topic of this session, cusp ligands demonstrate several similarities to the functional effects of HLA-G. The overall goal of this opinion articl …
Human leukocyte antigens (HLA) are significant genetic risk factors in a long list of diseases. ...Relevant to the topic of this sess …
HLA-G in Allergy: Does It Play an Immunoregulatory Role?
Negrini S, Contini P, Murdaca G, Puppo F. Negrini S, et al. Front Immunol. 2022 Jan 10;12:789684. doi: 10.3389/fimmu.2021.789684. eCollection 2021. Front Immunol. 2022. PMID: 35082780 Free PMC article. Review.
HLA-G expression and secretion is specifically induced in peripheral blood mononuclear cells of allergic patients after in vitro incubation with the causal allergen. ...HLA-G genetic polymorphisms confer susceptibility to allergic asthma development an …
HLA-G expression and secretion is specifically induced in peripheral blood mononuclear cells of allergic patients after in vit …
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.
Lin A, Yan WH. Lin A, et al. Front Immunol. 2021 Jun 30;12:698677. doi: 10.3389/fimmu.2021.698677. eCollection 2021. Front Immunol. 2021. PMID: 34276691 Free PMC article. Review.
HLA-G/ILT-2/-4 (HLA-G/ILTs) signaling can drive comprehensive immune suppression, promote tumor growth and disease progression. Though clinical benefits could be expected with application of HLA-G antibodies to blockade the HLA- …
HLA-G/ILT-2/-4 (HLA-G/ILTs) signaling can drive comprehensive immune suppression, promote tumor growth and disea …
HLA-G in asthma and its potential as an effective therapeutic agent.
Li J, Hao Y, Li W, Lv X, Gao P. Li J, et al. Allergol Immunopathol (Madr). 2023 Jan 1;51(1):22-29. doi: 10.15586/aei.v51i1.650. eCollection 2023. Allergol Immunopathol (Madr). 2023. PMID: 36617818 Review.
The mechanism of HLA-G in asthma is not fully clear, and there is no consensus on its mechanism in asthma. ...RESULTS: HLA-G is an important immunomodulatory factor in asthma. Studies have found different levels of HLA-G in patients with …
The mechanism of HLA-G in asthma is not fully clear, and there is no consensus on its mechanism in asthma. ...RESULTS: HLA …
2,919 results